Inventor · disambiguated record
John Babcook
Also filed as: BABCOOK JOHN · BABCOOK JOHN S · BABCOOK JOHN STEPHEN
25 granted patents·10 pending applications·743 citations·filing 2002–2023
96Inventor score
Files withZYMEWORKS INC5AMGEN FREMONT INC4MILLENNIUM PHARM INC4CENTRE FOR DRUG RES AND DEVELOPMENT3ABBOTT LAB2
Top patents by PatentIndex Score
35 records- 0195US9522876B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Dec 20, 2016·19 cites·48 claims
- 0295US8779108B2Targeted binding agents against B7-H1QUEVA CHRISTOPHE·Filed 2010·Granted Jul 15, 2014·452 cites·31 claims
- 0395US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 0493US8759490B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2012·Granted Jun 24, 2014·13 cites·12 claims
- 0592US9926378B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2016·Granted Mar 27, 2018·5 cites·18 claims
- 0691US8604174B2High affinity fully human monoclonal antibodies to interleukin-8BABCOOK JOHN·Filed 2006·Granted Dec 10, 2013·30 cites·7 claims
- 0791US7968684B2IL-18 binding proteinsABBOTT LAB·Filed 2004·Granted Jun 28, 2011·24 cites·64 claims
- 0888US7728110B2Antibodies to SARS coronavirusAMGEN INC·Filed 2007·Granted Jun 1, 2010·21 cites·15 claims
- 0988US7265212B2Anti-CD45RB antibodiesAMGEN FREMONT INC·Filed 2002·Granted Sep 4, 2007·33 cites·8 claims
- 1087US9421277B2Antibodies that bind OV064 and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Granted Aug 23, 2016·5 cites·12 claims
- 1186US8785600B2Anti-GCC antibody molecules and related compositions and methodsNAM SAMUEL S·Filed 2010·Granted Jul 22, 2014·10 cites·16 claims
- 1286US8323645B2Antibodies that bind OV064 and methods of use thereforVEIBY OLE PETTER·Filed 2006·Granted Dec 4, 2012·13 cites·9 claims
- 1383US10201614B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS INC·Filed 2014·Granted Feb 12, 2019·3 cites·38 claims
- 1482US12303544B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2023·Granted May 20, 2025·0 cites·24 claims
- 1580US2023235062A1Targeted binding agents against b7-h1MEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 1679US8431130B2IL-18 binding proteinsGHAYUR TARIQ·Filed 2010·Granted Apr 30, 2013·2 cites·50 claims
- 1777US11390673B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2019·Granted Jul 19, 2022·2 cites·17 claims
- 1876US11208497B2Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereofZYMEWORKS INC·Filed 2014·Granted Dec 28, 2021·2 cites·39 claims
- 1976US11090383B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2016·Granted Aug 17, 2021·2 cites·18 claims
- 2074US8101178B2Antibodies directed to tumor necrosis factor and uses thereofBABCOOK JOHN S·Filed 2007·Granted Jan 24, 2012·3 cites·21 claims
- 2172US11617777B2Cytotoxic and anti-mitotic compounds, and methods of using the sameZYMEWORKS BC INC·Filed 2019·Granted Apr 4, 2023·0 cites·23 claims
- 2269US10941211B2Anti-GCC antibody molecules and related compositions and methodsMILLENNIUM PHARM INC·Filed 2018·Granted Mar 9, 2021·0 cites·12 claims
- 2361US7754433B2Identification of high affinity molecules by limited dilution screeningAMGEN FREMONT INC·Filed 2002·Granted Jul 13, 2010·3 cites·20 claims
- 2456US12053524B2Anti-podocalyxin antibodies and methods of using the sameCENTRE FOR DRUG RES AND DEVELOPMENT·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
- 2556US2014322233A1Anti-gcc antibody molecules and related compositions and methodsNAM SAMUEL S·Filed 2014·Application pending·0 cites
- 2655US2014088296A1Il-18 binding proteinsABBOTT LAB·Filed 2013·Application pending·0 cites
- 2752US10675355B2VAR2CSA-drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jun 9, 2020·0 cites·43 claims
- 2852US2014105905A1High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such AntibodiesAMGEN FREMONT INC·Filed 2013·Application pending·0 cites
- 2951US2010196398A1Targeted binding agents directed to cd105 and uses thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 3050US2016264663A1Anti-podocalyxin antibodies and methods of using the sameTHE CENTRE FOR DRUG RES AND DEV·Filed 2014·Application pending·0 cites
- 3145US10517958B2Compositions and methods for the treatment of platinum-drug resistant cancerZYMEWORKS INC·Filed 2017·Granted Dec 31, 2019·0 cites·50 claims
- 3244US2005100965A1IL-18 binding proteinsFiled 2003·Application pending·0 cites
- 3343US2004053363A1Method for production of a multimeric protein by cell fusionFiled 2003·Application pending·0 cites
- 3441US2003175760A1Discovery of therapeutic productsFiled 2002·Application pending·0 cites
- 3540US2004053359A1Method for production of a multimeric protein by cell fusionFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Babcook files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →